193 related articles for article (PubMed ID: 25492830)
1. Amiloride lowers blood pressure and attenuates urine plasminogen activation in patients with treatment-resistant hypertension.
Oxlund CS; Buhl KB; Jacobsen IA; Hansen MR; Gram J; Henriksen JE; Schousboe K; Tarnow L; Jensen BL
J Am Soc Hypertens; 2014 Dec; 8(12):872-81. PubMed ID: 25492830
[TBL] [Abstract][Full Text] [Related]
2. Plasmin in urine from patients with type 2 diabetes and treatment-resistant hypertension activates ENaC in vitro.
Buhl KB; Oxlund CS; Friis UG; Svenningsen P; Bistrup C; Jacobsen IA; Jensen BL
J Hypertens; 2014 Aug; 32(8):1672-7; discussion 1677. PubMed ID: 24805959
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen Deficiency and Amiloride Mitigate Angiotensin II-Induced Hypertension in Type 1 Diabetic Mice Suggesting Effects Through the Epithelial Sodium Channel.
Andersen H; Hansen MH; Buhl KB; Stæhr M; Friis UG; Enggaard C; Supramaniyam S; Lund IK; Svenningsen P; Hansen PBL; Jensen BL
J Am Heart Assoc; 2020 Dec; 9(23):e016387. PubMed ID: 33215566
[TBL] [Abstract][Full Text] [Related]
4. Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine.
Stæhr M; Buhl KB; Andersen RF; Svenningsen P; Nielsen F; Hinrichs GR; Bistrup C; Jensen BL
Am J Physiol Renal Physiol; 2015 Aug; 309(3):F235-41. PubMed ID: 25972510
[TBL] [Abstract][Full Text] [Related]
5. Significant natriuretic and antihypertensive action of the epithelial sodium channel blocker amiloride in diabetic patients with and without nephropathy.
Andersen H; Hansen PB; Bistrup C; Nielsen F; Henriksen JE; Jensen BL
J Hypertens; 2016 Aug; 34(8):1621-9. PubMed ID: 27214087
[TBL] [Abstract][Full Text] [Related]
6. Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trial.
Oxlund CS; Henriksen JE; Tarnow L; Schousboe K; Gram J; Jacobsen IA
J Hypertens; 2013 Oct; 31(10):2094-102. PubMed ID: 24107738
[TBL] [Abstract][Full Text] [Related]
7. Amiloride resolves resistant edema and hypertension in a patient with nephrotic syndrome; a case report.
Hinrichs GR; Mortensen LA; Jensen BL; Bistrup C
Physiol Rep; 2018 Jun; 6(12):e13743. PubMed ID: 29939487
[TBL] [Abstract][Full Text] [Related]
8. Urinary plasmin activates collecting duct ENaC current in preeclampsia.
Buhl KB; Friis UG; Svenningsen P; Gulaveerasingam A; Ovesen P; Frederiksen-Møller B; Jespersen B; Bistrup C; Jensen BL
Hypertension; 2012 Nov; 60(5):1346-51. PubMed ID: 22987920
[TBL] [Abstract][Full Text] [Related]
9. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril.
Waeber B; Weidmann P; Wohler D; Le Bloch Y
Am J Hypertens; 1996 Dec; 9(12 Pt 1):1220-7. PubMed ID: 8972894
[TBL] [Abstract][Full Text] [Related]
10. Urokinase-type plasminogen activator contributes to amiloride-sensitive sodium retention in nephrotic range glomerular proteinuria in mice.
Hinrichs GR; Weyer K; Friis UG; Svenningsen P; Lund IK; Nielsen R; Mollet G; Antignac C; Bistrup C; Jensen BL; Birn H
Acta Physiol (Oxf); 2019 Dec; 227(4):e13362. PubMed ID: 31423748
[TBL] [Abstract][Full Text] [Related]
11. Diabetic nephropathy is associated with increased urine excretion of proteases plasmin, prostasin and urokinase and activation of amiloride-sensitive current in collecting duct cells.
Andersen H; Friis UG; Hansen PB; Svenningsen P; Henriksen JE; Jensen BL
Nephrol Dial Transplant; 2015 May; 30(5):781-9. PubMed ID: 25609736
[TBL] [Abstract][Full Text] [Related]
12. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of renal NaCl retention in proteinuric disease.
Svenningsen P; Friis UG; Versland JB; Buhl KB; Møller Frederiksen B; Andersen H; Zachar RM; Bistrup C; Skøtt O; Jørgensen JS; Andersen RF; Jensen BL
Acta Physiol (Oxf); 2013 Mar; 207(3):536-45. PubMed ID: 23216619
[TBL] [Abstract][Full Text] [Related]
14. Amiloride Reduces Urokinase/Plasminogen-Driven Intratubular Complement Activation in Glomerular Proteinuria.
Isaksson GL; Hinrichs GR; Andersen H; Bach ML; Weyer K; Zachar R; Henriksen JE; Madsen K; Lund IK; Mollet G; Bistrup C; Birn H; Jensen BL; Palarasah Y
J Am Soc Nephrol; 2024 Apr; 35(4):410-425. PubMed ID: 38254266
[TBL] [Abstract][Full Text] [Related]
15. Amiloride evokes significant natriuresis and weight loss in kidney transplant recipients with and without albuminuria.
Hinrichs GR; Nielsen JR; Birn H; Bistrup C; Jensen BL
Am J Physiol Renal Physiol; 2023 Oct; 325(4):F426-F435. PubMed ID: 37560772
[TBL] [Abstract][Full Text] [Related]
16. Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study.
Nielsen SE; Persson F; Frandsen E; Sugaya T; Hess G; Zdunek D; Shjoedt KJ; Parving HH; Rossing P
Diabet Med; 2012 Aug; 29(8):e184-90. PubMed ID: 22268920
[TBL] [Abstract][Full Text] [Related]
17. Albuminuria in kidney transplant recipients is associated with increased urinary serine proteases and activation of the epithelial sodium channel.
Hinrichs GR; Michelsen JS; Zachar R; Friis UG; Svenningsen P; Birn H; Bistrup C; Jensen BL
Am J Physiol Renal Physiol; 2018 Jul; 315(1):F151-F160. PubMed ID: 29363322
[TBL] [Abstract][Full Text] [Related]
18. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of long-term blood pressure control and vascular health by low-dose amiloride-based therapy in hyperaldosteronism.
Izzo JL; Hong M; Hussain T; Osmond PJ
J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1183-1190. PubMed ID: 31347775
[TBL] [Abstract][Full Text] [Related]
20. Urine albumin is a superior predictor of preeclampsia compared to urine plasminogen in type I diabetes patients.
Nielsen LH; Jensen BL; Fuglsang J; Andersen LLT; Jensen DM; Jørgensen JS; Kitlen G; Ovesen P
J Am Soc Hypertens; 2018 Feb; 12(2):97-107. PubMed ID: 29305116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
